- Home
- SDHY vs ANGO Comparison
SDHY vs ANGO Comparison
Compare SDHY & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SDHY
- ANGO
- Stock Information
- Founded
- SDHY 2020
- ANGO 1988
- Country
- SDHY United States
- ANGO United States
- Employees
- SDHY N/A
- ANGO N/A
- Industry
- SDHY Finance/Investors Services
- ANGO Medical/Dental Instruments
- Sector
- SDHY Finance
- ANGO Health Care
- Exchange
- SDHY Nasdaq
- ANGO Nasdaq
- Market Cap
- SDHY 409.3M
- ANGO 401.4M
- IPO Year
- SDHY N/A
- ANGO 2004
- Fundamental
- Price
- SDHY $16.53
- ANGO $9.39
- Analyst Decision
- SDHY
- ANGO Strong Buy
- Analyst Count
- SDHY 0
- ANGO 3
- Target Price
- SDHY N/A
- ANGO $13.00
- AVG Volume (30 Days)
- SDHY 94.0K
- ANGO 479.1K
- Earning Date
- SDHY 01-01-0001
- ANGO 04-02-2025
- Dividend Yield
- SDHY 8.46%
- ANGO N/A
- EPS Growth
- SDHY N/A
- ANGO N/A
- EPS
- SDHY 1.07
- ANGO N/A
- Revenue
- SDHY N/A
- ANGO $286,498,000.00
- Revenue This Year
- SDHY N/A
- ANGO N/A
- Revenue Next Year
- SDHY N/A
- ANGO $6.63
- P/E Ratio
- SDHY $14.31
- ANGO N/A
- Revenue Growth
- SDHY N/A
- ANGO N/A
- 52 Week Low
- SDHY $13.93
- ANGO $5.47
- 52 Week High
- SDHY $15.50
- ANGO $13.50
- Technical
- Relative Strength Index (RSI)
- SDHY 51.98
- ANGO 43.99
- Support Level
- SDHY $16.45
- ANGO $9.34
- Resistance Level
- SDHY $16.73
- ANGO $10.29
- Average True Range (ATR)
- SDHY 0.15
- ANGO 0.39
- MACD
- SDHY 0.01
- ANGO 0.06
- Stochastic Oscillator
- SDHY 69.58
- ANGO 32.84
About SDHY PGIM Short Duration High Yield Opportunities Fund
PGIM Short Duration High Yield Opportunities is a closed-end management investment company. The fund's investment objective is to provide total return, through a combination of current income and capital appreciation. Its seeks to achieve its objective by investing in a diversified portfolio of high yield fixed income instruments.
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.